New Journey Health Technology Group Co.,LTD (SHE:002219)

Market Cap	8.04B -5.2%
Revenue (ttm)	3.11B -28.6%
Net Income	19.58M -62.5%
EPS	0.01 -61.9%
Shares Out	3.38B
PE Ratio	410.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,033,776
Average Volume	130,494,124
Open	2.390
Previous Close	2.390
Day's Range	2.370 - 2.410
52-Week Range	2.030 - 3.000
Beta	0.47
RSI	49.40
Earnings Date	Apr 3, 2026

About SHE:002219

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Schisandra tablets, Maiping tablets, Prosta Antong tablets, Gongzhongning capsules, Wuhu San, Wei Funing capsules, and other pro...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2001
• Employees: 9,097
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002219

Financial Performance

In 2024, SHE:002219's revenue was 3.80 billion, a decrease of -2.95% compared to the previous year's 3.91 billion. Earnings were 114.77 million, an increase of 296.13%.